Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock

News
2021
2020
Archive

August 24, 2021

Nouscom Announces First Patient Dosed in a Phase 1B Trial with NOUS-PEV, a Novel Personalized Cancer Immunotherapy, in Advanced Melanoma or Lung Cancer
August 2, 2021

Rallybio Corporation Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
July 29, 2021

Rallybio Corporation Announces Pricing of Initial Public Offering
July 29, 2021

CinCor Pharma Appoints Marc de Garidel as Chief Executive Officer
July 29, 2021

Pear Therapeutics Announces Publication of Healthcare Resource Utilization Data Analysis Showing Real-World Cost Impact of reSET-O in Treating Opioid Use Disorder
July 27, 2021

Cidara Therapeutics to Present New Data for Rezafungin at the International Society for Human and Animal Mycology (ISHAM) Asia Congress
July 22, 2021

Arvinas and Pfizer Announce Global Collaboration to Develop and Commercialize PROTAC® Protein Degrader ARV-471
July 21, 2021

TMRW Life Sciences Raises $105 Million to Accelerate Global Rollout of World’s First Automated Platform for IVF Egg & Embryo Management
July 21, 2021

Ninilchik Village Tribe Will Provide Access to Prescription Digital Therapeutics to Help Alaskan Community Treat Rural Patients with Substance and Opioid Use Disorder
July 16, 2021

Escient Pharmaceuticals Announces Positive Results From Phase 1 Study Of EP547, An MrgprX4-Targeted Oral Therapy For Cholestatic And Uremic Pruritus

© 2021 5AM Venture Management LLC